IMO this stock is definately under valued considering the different applications for recaf. Historically this stock moves up on press releases then drops back down to previous levels after a few days. I'm curious to see if the current volume continues. There's really not much at this stage to hold the share price up unless we get some more press releases, in the next few days. I've held the opinion for some time that we will continue to see the share price depressed until revenues start flowing and/or Recaf receives FDA approval. Once that happens there's no telling where this stock will go. The possibilities for Recaf are enourmous.

I'm sure the current financial state of our economy, job loses, loses in the market affect the share price of Biocurex considering this environment has affected most if not all of the publically traded companies. Don't forget the Goldseeker factor although I'm not really sure how much impact if any he has on the share price. I do suspect that people (professionals) are working in unision to keep the share price down for what ever reason. We've all seen good blue chip stocks lose 50% or more of their market value, but I've recently seen some penny stocks move up 500% - 800% in a few days or weeks. Once the big press releases come out, I predict a similar upward movement of Biocurex. I even suspect it will move up more than 800%. After all from the current share price that's only .90/share.A few years back this stock almost reached 4 dollars/share in about a 2 week period, when everyone thought Recaf had received FDA approval. About a year after that event I talked to someone in investor relations for Biocurex and then they put a value of $2.5 - $3.0/share on Biocurex at that time. This was before the agreements with Abbott and Inverness were even signed.

I'm sure someone else on the board can put a more realistic value on the Biocurex based on projected revenues. If memory serves me correctly, I beleive the value calculated in the past was some where between $5 - $10/share.

One thing I would like to point out is there have been on-going discussions about Recaf being used on cancer patients for monitoring after surgery rather than diagnostics because of the false positives (telling a patient they have cancer when they don't). It was also suggested by Dr. Moro that Recaf could be used during surgery to test tissue to make sure all the cancer was removed before sewing/stapling the patient up. That test takes about 30 minutes. Using Recaf for monitoring rather than diagnostics was perceived by Goldseeker as negative. Obviuosly his mind and my mind don't work the same because I view monitoring as positive. When I had my kidney transplant back in January of 2008, blood test were run on me daily for the first week while in the hospital, after leaving the hospital once per week, then once every two weeks and so on eventually tapering off to once every six months. I'm sure once a cancer patient had surgery Doctors would use a similiar frequency for testing the patient to make sure the cancer was removed or at least in remission. I know I may not be the smartest person at times, but I believe Biocurex would receive more revenues for mutilpe tests for monitoring than a one time test for diagnotics, that's not to say Racaf still can't be used for for diagnostics.

JMHO